Hochschulschrift
Genomic characterization of clonal evolution in NPM1 mutated acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
XI, 87 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Universität Ulm, Dissertation, 2019
- Schlagwort
-
Akute myeloische Leukämie
Genomik
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2019
Ähnliche Objekte (12)
Sensitive quantification of clonal evolution in Acute Myeloid Leukemia
The genomic & transcriptomic landscape of acute myeloid leukemia
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
The role of KDM6A in the clonal evolution of acute myeloid leukemia
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Computational Reconstruction of Clonal Hierarchies From Bulk Sequencing Data of Acute Myeloid Leukemia Samples
Genetic and clonal changes in myelodysplastic syndromes and upon transformation to acute myeloid leukemia
The role of pre-leukemic stem cells in clonal evolution of acute myeloid leukemia
Deciphering the role of GPX4 in acute myeloid leukemia and identification of SMC4 as a possible novel therapeutic target in NPM1-mutated acute myeloid leukemia
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
Sensitive quantification of clonal evolution in Acute Myeloid Leukemia
The genomic & transcriptomic landscape of acute myeloid leukemia
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
The role of KDM6A in the clonal evolution of acute myeloid leukemia
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Computational Reconstruction of Clonal Hierarchies From Bulk Sequencing Data of Acute Myeloid Leukemia Samples
Genetic and clonal changes in myelodysplastic syndromes and upon transformation to acute myeloid leukemia
The role of pre-leukemic stem cells in clonal evolution of acute myeloid leukemia
Deciphering the role of GPX4 in acute myeloid leukemia and identification of SMC4 as a possible novel therapeutic target in NPM1-mutated acute myeloid leukemia
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
Sensitive quantification of clonal evolution in Acute Myeloid Leukemia
The genomic & transcriptomic landscape of acute myeloid leukemia
Multi-omics analysis of DNMT3A- and NPM1-mutated acute myeloid leukemia
The role of KDM6A in the clonal evolution of acute myeloid leukemia
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
Computational Reconstruction of Clonal Hierarchies From Bulk Sequencing Data of Acute Myeloid Leukemia Samples
Genetic and clonal changes in myelodysplastic syndromes and upon transformation to acute myeloid leukemia
The role of pre-leukemic stem cells in clonal evolution of acute myeloid leukemia
Deciphering the role of GPX4 in acute myeloid leukemia and identification of SMC4 as a possible novel therapeutic target in NPM1-mutated acute myeloid leukemia
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis